Article
Metabolism‐Based Molecular Subtyping Endows Effective Ketogenic Therapy in p53‐Mutant Colon Cancer
28 Aug 2022
Abstract excerpt
Abstract Although targeting cancer metabolism is a promising therapeutic strategy, clinical success depends on accurate molecular and metabolic subtyping. Here, this study reports two metabolism‐based molecular subtypes associated with the ketogenic treatment of colon cancer: glycolytic (glycolysis + /ketolysis − ) and ketolytic (glycolysis + /ketolysis + ), which are manifested by distinct profiles of metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
